QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of equity awards to two newly hired, non-executive employees (the "Inducement Grants"). The Inducement Grants were granted pursuant to the Company's 2026 Inducement Plan and as an inducement material to each employee's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

The Inducement Grants consist of restricted stock units ("RSUs") with respect to an aggregate of 50,323 shares of the Company's common stock. The RSUs were granted with a grant date of October 15, 2026, and will vest in equal annual installments on the first three anniversaries of the grant date, subject to the employee's continued employment with the Company through each applicable vesting date. The RSUs are subject to the terms and conditions of the 2026 Inducement Plan and the terms and conditions of a RSU award agreement covering each Inducement Grant.